EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery

Uppula Purushotham iD

Advanced Pharmaceutical Bulletin · 31.08.2025

DOI: 10.34172/apb.025.45948 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 31.08.2025. Verfasst von Uppula Purushotham. Beteiligte Einrichtung: Department of Chemistry, Guru Nanak Institutions Technical Campus, School of engineering and Technology Hyderabad, Telangana, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Chemistry, Guru Nanak Institutions Technical Campus, School of engineering and Technology Hyderabad, Telangana, India.

ORCID-Profile: Uppula Purushotham

Zitieren

APA

Purushotham, U. (2025). Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.025.45948

Vancouver

Purushotham U. Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery. Advanced Pharmaceutical Bulletin. 2025. doi:10.34172/apb.025.45948

BibTeX
@article{Purushotham2025,
  author = {Purushotham, Uppula},
  title = {Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery},
  journal = {Advanced Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.34172/apb.025.45948}
}
Kostenlos starten →